Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAST-TaxXel: Docetaxel and Capecitabine in Advanced Gastric Cancer
NCT00669370Phase 2Unknown
- Sponsor
- University of Turku
- Start
- Jun 2006
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of docetaxel in gastric adenocarcinoma, sponsored by University of Turku. Status: unknown.
02
Drugs
docetaxel
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT00669370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00669370.